EBOS Group Ltd (EBO) is a $5.2bn leading Australasian company that distributes healthcare, medical, pharmaceutical, and animal care products. Its healthcare division includes brands like Symbion, TerryWhite Chemmart, and LifeHealthcare, while its animal care segment offers products under brands such as Black Hawk and Vitapet.
We discussed EBO earlier in the month in our Q&A after the stock came under pressure following a trifecta of bad news: weaker-than-expected FY25 results, the loss of a major $2B Chemist Warehouse contract, and a large shareholder (Sybos) offloading nearly 13% of the company. At this stage, we cannot see any quick turnaround for EBO, placing the stock firmly in the too-hard basket.
- We continue to have no interest in EBO.
MM is neutral towards EBO
Add To Hit List
